Michael Rigby

Title: Michael Rigby: Innovator in Peptide Ligand Technology

Introduction

Michael Rigby is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of peptide ligands, holding a total of four patents. His work focuses on developing innovative solutions for medical applications, particularly in the area of targeted drug delivery.

Latest Patents

Michael Rigby's latest patents include groundbreaking inventions such as "Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)" and "Bicyclic peptide ligands specific for nectin-4." The first patent describes polypeptides that are covalently bound to molecular scaffolds, allowing for the creation of multimeric binding complexes that can effectively target TfR1. This invention has potential applications in preventing and treating diseases through TfR1 mediated delivery of therapeutic agents. The second patent focuses on high-affinity binders of Nectin-4, which can be used in drug conjugates to treat disorders mediated by this receptor.

Career Highlights

Michael Rigby is currently associated with Bicycletx Limited, where he continues to advance his research and development efforts. His innovative work has positioned him as a key player in the field of peptide technology, contributing to the development of new therapeutic strategies.

Collaborations

Michael collaborates with talented individuals such as Gemma Elizabeth Mudd and Katerine Van Rietschoten. Their combined expertise enhances the research and development efforts at Bicycletx Limited.

Conclusion

Michael Rigby is a prominent inventor whose work in peptide ligands is paving the way for new medical advancements. His contributions are vital in the ongoing quest for effective treatments and therapies.